secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definitive Healthcare Corp. (DH)
CIK:        0001861795
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0001193125-25-269559
Event type: earnings
Sentiment:  neutral
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Definitive Healthcare Q3 revenue $60M (-4% YoY); net loss $17.8M; raises FY revenue guidance low end
--------------------------------------------------------------------------------

- Revenue $60.0M (-4% vs $62.7M in Q3 2024); net loss $17.8M (vs $187.8M including $228.2M goodwill impairment).
- Adjusted EBITDA $18.9M (32% margin), down from $20.6M (33% margin) YoY; adjusted net income $9.7M.
- Q4 2025 revenue guidance $59-60M; FY 2025 revenue guidance raised to $239-240M (low end up $2M).
- Customer wins: large biopharma and medical device company selected Definitive Healthcare for commercial intelligence.
- Cash flow from operations $15.7M; unlevered free cash flow $17.9M in Q3 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861795/000119312525269559/0001193125-25-269559-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861795/000119312525269559/dh-20251106.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-269559

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer